ALDConnect Announcements – 11.12.2015

Has your child with CCALD received an allogeneic HSCT in the last two years? If so, please ask your physician about the ALD-103 Study (Protocol), a new data collection study that is now open. The purpose of the ALD-103 Study is to better understand the safety and efficacy outcomes of the standard of care treatment for CCALD–allogeneic hematopoietic stem cell […]